DSCR9 and pancreatic neoplasm: Since BTG2 has been reported to be targeted by several miRNAs within pancreatic carcinomas, such as miR-21[37] and miR-27a[29], we speculate that there might be other miRNAs mediating the crosstalk between DSCR9 and BTG2 in pancreatic cancer cells.